Search Results

There are 4562 results for: content related to: Conversion to everolimus in maintenance liver transplant patients: A multicenter, retrospective analysis

  1. You have free access to this content
    Mechanisms of Everolimus-Induced Glomerulosclerosis After Glomerular Injury in the Rat

    American Journal of Transplantation

    Volume 5, Issue 12, December 2005, Pages: 2849–2861, C. Daniel, L. Renders, K. Amann, E. Schulze-Lohoff, I.A. Hauser and C. Hugo

    Version of Record online : 18 NOV 2005, DOI: 10.1111/j.1600-6143.2005.01120.x

  2. You have free access to this content
    Everolimus Plus Reduced-Exposure CsA versus Mycophenolic Acid Plus Standard-Exposure CsA in Renal-Transplant Recipients

    American Journal of Transplantation

    Volume 10, Issue 6, June 2010, Pages: 1401–1413, H. Tedesco Silva Jr., D. Cibrik, T. Johnston, E. Lackova, K. Mange, C. Panis, R. Walker, Z. Wang, G. Zibari and Y. S. Kim

    Version of Record online : 28 APR 2010, DOI: 10.1111/j.1600-6143.2010.03129.x

  3. Influence of Everolimus on Steady-State Pharmacokinetics of Cyclosporine in Maintenance Renal Transplant Patients

    The Journal of Clinical Pharmacology

    Volume 45, Issue 7, July 2005, Pages: 781–791, Dr Klemens Budde, Dr Gustav Lehne, Dr Michael Winkler, Dr Lutz Renders, Dr Arno Lison, Dr Lutz Fritsche, Dr Jean-Paul Soulillou, Dr Per Fauchald, Dr Hans-Hellmut Neumayer, Dr Jaques Dantal and Behalf of the RADW 102 Renal Transplant Study Group

    Version of Record online : 25 MAR 2013, DOI: 10.1177/0091270005277196

  4. You have full text access to this OnlineOpen article
    Therapeutic potential and adverse events of everolimus for treatment of hepatocellular carcinoma – systematic review and meta-analysis

    Cancer Medicine

    Volume 2, Issue 6, December 2013, Pages: 862–871, Kenya Yamanaka, Marius Petrulionis, Shibo Lin, Chao Gao, Uwe Galli, Susanne Richter, Susanne Winkler, Philipp Houben, Daniel Schultze, Etsuro Hatano and Peter Schemmer

    Version of Record online : 22 OCT 2013, DOI: 10.1002/cam4.150

  5. You have free access to this content
    Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain

    Liver Transplantation

    Volume 21, Issue 8, August 2015, Pages: 1056–1065, Itxarone Bilbao, Magdalena Salcedo, Miguel Angel Gómez, Carlos Jimenez, Javier Castroagudín, Joan Fabregat, Carolina Almohalla, Ignacio Herrero, Valentín Cuervas-Mons, Alejandra Otero, Angel Rubín, Manuel Miras, Juan Rodrigo, Trinidad Serrano, Gonzalo Crespo, Manuel De la Mata, Javier Bustamante, M. Luisa Gonzalez-Dieguez, Antonia Moreno, Isidoro Narvaez, Magda Guilera and for the EVEROLIVER study group

    Version of Record online : 24 JUL 2015, DOI: 10.1002/lt.24172

  6. Development of everolimus, a novel oral mTOR inhibitor, across a spectrum of diseases

    Annals of the New York Academy of Sciences

    Volume 1291, Issue 1, July 2013, Pages: 14–32, David Lebwohl, Özlem Anak, Tarek Sahmoud, Judith Klimovsky, Ingrid Elmroth, Tomas Haas, Joseph Posluszny, Stephen Saletan and William Berg

    Version of Record online : 9 MAY 2013, DOI: 10.1111/nyas.12122

  7. Blood Concentrations of Everolimus Are Markedly Increased by Ketoconazole

    The Journal of Clinical Pharmacology

    Volume 45, Issue 5, May 2005, Pages: 514–528, Dr J. M. Kovarik, Dr D. Beyer, Dr M. N. Bizot, Dr Q. Jiang, Dr M. Shenouda and Dr R. L. Schmouder

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270005275368

  8. You have free access to this content
    Therapeutic Drug Monitoring for Everolimus in Heart Transplant Recipients Based on Exposure–Effect Modeling

    American Journal of Transplantation

    Volume 4, Issue 12, December 2004, Pages: 2126–2131, Randall C. Starling, Joshua M. Hare, Paul Hauptman, Kenneth R. McCurry, Hartmut W. Mayer, John M. Kovarik and Heinz Schmidli

    Version of Record online : 4 OCT 2004, DOI: 10.1046/j.1600-6143.2004.00601.x

  9. Economic evaluation of everolimus vs. azathioprine at one year after de novo heart transplantation

    Clinical Transplantation

    Volume 19, Issue 1, February 2005, Pages: 122–129, Jasmina I. Radeva, Shelby D. Reed, Zoltán Kaló, Teresa L. Kauf, Edward Cantu III, Nathalie Cretin and Kevin A. Schulman

    Version of Record online : 16 DEC 2004, DOI: 10.1111/j.1399-0012.2004.00312.x

  10. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: Pharmacokinetics, exposure-response relationships, and influence on cyclosporine

    Clinical Pharmacology & Therapeutics

    Volume 69, Issue 1, January 2001, Pages: 48–56, John M. Kovarik, Barry D. Kahan, Bruce Kaplan, Marc Lorber, Michael Winkler, Marisel Rouilly, Christophe Gerbeau, Natalie Cambon, Robert Boger, Christiane Rordorf and on behalf of the Everolimus Phase 2 Study Group

    Version of Record online : 5 JAN 2001, DOI: 10.1067/mcp.2001.112969

  11. You have full text access to this OnlineOpen article
    Synergistic activity of everolimus and 5-aza-2′-deoxycytidine in medullary thyroid carcinoma cell lines

    Molecular Oncology

    Volume 11, Issue 8, August 2017, Pages: 1007–1022, Giovanni Vitale, Alessandra Dicitore, Daniele Pepe, Davide Gentilini, Elisa S. Grassi, Maria O. Borghi, Giulia Gelmini, Maria C. Cantone, Germano Gaudenzi, Gabriella Misso, Anna M. Di Blasio, Leo J. Hofland, Michele Caraglia and Luca Persani

    Version of Record online : 21 JUN 2017, DOI: 10.1002/1878-0261.12070

  12. You have free access to this content
    Everolimus Versus Mycophenolate Mofetil in Heart Transplantation: A Randomized, Multicenter Trial

    American Journal of Transplantation

    Volume 13, Issue 5, May 2013, Pages: 1203–1216, H. J. Eisen, J. Kobashigawa, R. C. Starling, D. F. Pauly, A. Kfoury, H. Ross, S.-S. Wang, B. Cantin, A. Van Bakel, G. Ewald, S. Hirt, H. Lehmkuhl, A. Keogh, M. Rinaldi, L. Potena, A. Zuckermann, G. Dong, C. Cornu-Artis and P. Lopez

    Version of Record online : 22 FEB 2013, DOI: 10.1111/ajt.12181

  13. You have free access to this content
    The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial

    American Journal of Transplantation

    Volume 15, Issue 7, July 2015, Pages: 1967–1975, S. Arora, A. K. Andreassen, B. Andersson, F. Gustafsson, H. Eiskjær, H. E. Bøtker, G. Rådegran, E. Gude, D. Ioanes, D. Solbu, V. Sigurdardottir, G. Dellgren, I. Erikstad, O. G. Solberg, T. Ueland, P. Aukrust, L. Gullestad and on behalf of the SCHEDULE (SCandinavian HEart transplant everolimus De novo stUdy with earLy calcineurin inhibitors avoidancE) Investigators

    Version of Record online : 17 MAR 2015, DOI: 10.1111/ajt.13214

  14. You have free access to this content
    Conversion From Cyclosporine to Everolimus at 4.5 Months Posttransplant: 3-Year Results From the Randomized ZEUS Study

    American Journal of Transplantation

    Volume 12, Issue 6, June 2012, Pages: 1528–1540, K. Budde, F. Lehner, C. Sommerer, W. Arns, P. Reinke, U. Eisenberger, R. P. Wüthrich, S. Scheidl, C. May, E.-M. Paulus, A. Mühlfeld, H. H. Wolters, K. Pressmar, R. Stahl, O. Witzke and On behalf of the ZEUS Study Investigators

    Version of Record online : 5 MAR 2012, DOI: 10.1111/j.1600-6143.2012.03994.x

    Corrected by:

    Erratum

    Vol. 12, Issue 11, 3165, Version of Record online: 27 OCT 2012

  15. You have free access to this content
    Three-Year Efficacy and Safety Results from a Study of Everolimus Versus Mycophenolate Mofetil in de novo Renal Transplant Patients

    American Journal of Transplantation

    Volume 5, Issue 10, October 2005, Pages: 2521–2530, Štefan Vítko, Raimund Margreiter, Willem Weimar, Jacques Dantal, Dirk Kuypers, Michael Winkler, Ole Øyen, Hendrik G. Viljoen, Pavel Filiptsev, Sami Sadek, Yulan Li, Nathalie Cretin, Klemens Budde and for the RAD B201 Study Group

    Version of Record online : 11 SEP 2005, DOI: 10.1111/j.1600-6143.2005.01063.x

  16. You have free access to this content
    Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck

    Cancer

    Volume 120, Issue 24, December 15, 2014, Pages: 3940–3951, Nabil F. Saba, Selwyn J. Hurwitz, Kelly Magliocca, Sungjin Kim, Taofeek K. Owonikoko, Donald Harvey, Suresh S. Ramalingam, Zhengjia Chen, Jackie Rogerio, Jennifer Mendel, Scott A. Kono, Colleen Lewis, Amy Y. Chen, Kristin Higgins, Mark El-Deiry, Trad Wadsworth, Jonathan J. Beitler, Dong M. Shin, Shi-Yong Sun and Fadlo R. Khuri

    Version of Record online : 7 AUG 2014, DOI: 10.1002/cncr.28965

  17. You have free access to this content
    Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancer

    Cancer

    Volume 110, Issue 3, 1 August 2007, Pages: 599–605, Daniel T. Milton, Gregory J. Riely, Christopher G. Azzoli, Jorge E. Gomez, Robert T. Heelan, Mark G. Kris, Lee M. Krug, William Pao, Barbara Pizzo, Naiyer A. Rizvi and Vincent A. Miller

    Version of Record online : 18 JUN 2007, DOI: 10.1002/cncr.22816

  18. Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized Trial

    American Journal of Transplantation

    Volume 17, Issue 7, July 2017, Pages: 1843–1852, F. Saliba, C. Duvoux, J. Gugenheim, N. Kamar, S. Dharancy, E. Salamé, M. Neau-Cransac, F. Durand, P. Houssel-Debry, C. Vanlemmens, G. Pageaux, J. Hardwigsen, D. Eyraud, Y. Calmus, F. Di Giambattista, J. Dumortier and F. Conti

    Version of Record online : 10 MAR 2017, DOI: 10.1111/ajt.14212

  19. You have free access to this content
    The therapeutic potential of mTOR inhibitors in breast cancer

    British Journal of Clinical Pharmacology

    Volume 82, Issue 5, November 2016, Pages: 1189–1212, Linda S. Steelman, Alberto M. Martelli, Lucio Cocco, Massimo Libra, Ferdinando Nicoletti, Stephen L. Abrams and James A. McCubrey

    Version of Record online : 10 MAY 2016, DOI: 10.1111/bcp.12958

  20. Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial

    American Journal of Transplantation

    Volume 17, Issue 7, July 2017, Pages: 1853–1867, J. W. de Fijter, H. Holdaas, O. Øyen, J.-S. Sanders, S. Sundar, F. J. Bemelman, C. Sommerer, J. Pascual, Y. Avihingsanon, C. Pongskul, F. Oppenheimer, L. Toselli, G. Russ, Z. Wang, P. Lopez, J. Kochuparampil, J. M. Cruzado, M. van der Giet and on behalf of the ELEVATE Study Group

    Version of Record online : 14 FEB 2017, DOI: 10.1111/ajt.14186